CYN Cyngn falls 457 after Q3 2025 EPS misses analyst estimates by 188 percent AVAV AeroViron Q1 2026 EPS lags analyst estimates by 93 stock slips 279 following softer quarterly results What Wall Street expects from Kyverna Therapeutics KYTX this quarter KYTX Q4 2025 Kyverna Therapeutics Beats EPS Estimates with Zero Revenue What Strategy STRD is doing to stay ahead Risk Aversion 20260508